Abstract
Gene silencing by RNA interference (RNAi) has become a standard method for the characterization of gene function in mammalian cells. Short hairpin (sh) RNAs expressed from stably integrated vectors mediate gene knockdown both in cultured cells and in mice, presenting a fast alternative to gene knockout approaches. We describe three strategies to control gene silencing in mice that can be applied to any transcript of interest. This shRNA based approach enables either i) constitutive body-wide knockdown, ii) cell type-specific knockdown controlled by Cre recombinase, or iii) inducible body-wide knockdown controlled by doxycycline. For reliable expression the shRNA vector of interest is inserted into a Rosa26 docking site of ES cells by a site-specific recombinase. These ES cells can then be used to generate shRNA transgenic mice. This technology enables the production of adult knockdown mice within 11 months for an expedite in vivo validation of drug targets.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Elbashir SM, Harborth J, Lendeckel W et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498
Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553
Paddison PJ, Caudy AA, Bernstein E et al (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16:948–958
Kuhn R, Streif S, Wurst W (2007) RNA interference in mice. Handb Exp Pharmacol 178:149–176
Dykxhoorn DM, Chowdhury D, Lieberman J (2008) RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv Exp Med Biol 615:299–329
Dykxhoorn DM, Lieberman J (2006) Knocking down disease with siRNAs. Cell 126:231–235
Vaishnaw AK, Gollob J, Gamba-Vitalo C et al (2010) A status report on RNAi therapeutics. Silence 1:14
Falschlehner C, Steinbrink S, Erdmann G et al (2010) High-throughput RNAi screening to dissect cellular pathways: a how-to guide. Biotechnol J 5:368–376
Seyhan AA, Rya TE (2010) RNAi screening for the discovery of novel modulators of human disease. Curr Pharm Biotechnol 11:735–756
Seyhan AA, Varadarajan U, Choe S et al (2011) A genome-wide RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and paclitaxel combination drug treatments. Mol BioSyst 7:1974–1989
Tiedemann RE, Zhu YX, Schmidt J et al (2010) Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6. Blood 115:1594–1604
Zhu YX, Tiedemann R, Shi CX et al (2011) RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5. Blood 117:3847–3857
Delic S, Streif S, Deussing JM et al (2008) Genetic mouse models for behavioral analysis through transgenic RNAi technology. Genes Brain Behav 7:821–830
Kunath T, Gish G, Lickert H et al (2003) Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol 21:559–561
Hasuwa H, Kaseda K, Einarsdottir T et al (2002) Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 532:227–230
Hitz C, Wurst W, Kuhn R (2007) Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference. Nucleic Acids Res 35:e90
Rubinson DA, Dillon CP, Kwiatkowski AV et al (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401–406
Seibler J, Küter-Luks B, Kern H et al (2005) Single copy shRNA configuration for ubiquitous gene knockdown in mice. Nucleic Acids Res 33:e67
Steuber-Buchberger P, Wurst W, Kuhn R (2008) Simultaneous Cre-mediated conditional knockdown of two genes in mice. Genesis 46:144–151
Seibler J, Kleinridders A, Küter-Luks B et al (2007) Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Res 35:e54
Nagy A, Mar L, Watts G (2009) Creation and use of a cre recombinase transgenic database. Methods Mol Biol 530:365–378
van de Wetering M, Oving I, Muncanet V et al (2003) Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4:609–615
Wiznerowicz M, Szulc J, Trono D (2006) Tuning silence: conditional systems for RNA interference. Nat Methods 3:682–688
Acehan D, Vaz F, Houtkooper RH et al (2011) Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J Biol Chem 286:899–908
He G, Luo W, Li P et al (2010) Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease. Nature 467:95–98
Jordan SD, Krüger M, Willmes DM et al (2011) Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 13:434–446
Koch L, Wunderlich FT, Seibler J et al (2008) Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 118:2132–2147
Kotnik K, Popova E, Todiras M et al (2009) Inducible transgenic rat model for diabetes mellitus based on shRNA-mediated gene knockdown. PLoS One 4:e5124
Herold MJ, van den Brandt J, Seibler J et al (2008) Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc Natl Acad Sci USA 105:18507–18512
Christoph T, Bahrenberg G, De Vry J et al (2008) Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice. Mol Cell Neurosci 37:579–589
Sacca R, Engle SJ, Qin W et al (2010) Genetically engineered mouse models in drug discovery research. Methods Mol Biol 602:37–54
Yang R, Castriota G, Chen Z et al (2011) RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice. Int J Obes 35:217–225
Reid SW, Tessarollo L (2009) Isolation, microinjection and transfer of mouse blastocysts. Methods Mol Biol 530:269–285
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 SpringerScience+Business Media New York
About this protocol
Cite this protocol
Kleinhammer, A., Wurst, W., Kühn, R. (2013). Target Validation in Mice by Constitutive and Conditional RNAi. In: Moll, J., Colombo, R. (eds) Target Identification and Validation in Drug Discovery. Methods in Molecular Biology, vol 986. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-311-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-62703-311-4_19
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-310-7
Online ISBN: 978-1-62703-311-4
eBook Packages: Springer Protocols